Measurement of binding anti-IFNbeta antibodies in IFNbeta-treated MS patients: lessons for the clinician and basic scientist.
Pachner
Andrew R
AR
D000937:Antigen-Antibody Reactions; D016903:Drug Monitoring; D004797:Enzyme-Linked Immunosorbent Assay / Q000191:economics / Q000706:statistics & numerical data; D006801:Humans; D007155:Immunologic Factors / Q000276:immunology / Q000627:therapeutic use; D007370:Interferon Type I / Q000276:immunology* / Q000627:therapeutic use; D007518:Isoantibodies / Q000096:biosynthesis* / Q000276:immunology; D009103:Multiple Sclerosis / Q000276:immunology* / Q000628:therapy; D009500:Neutralization Tests; D011237:Predictive Value of Tests; D011994:Recombinant Proteins
D007155:Immunologic Factors; D007370:Interferon Type I; D007518:Isoantibodies; D011994:Recombinant Proteins